1. Home
  2. Publications
  3. A novel combined targeted therapy with bromodomain antagonist and MEK inhibitor in anaplastic thyroid cancer.

A novel combined targeted therapy with bromodomain antagonist and MEK inhibitor in anaplastic thyroid cancer.

Nucera, Carmelo. 2019. “A Novel Combined Targeted Therapy With Bromodomain Antagonist and MEK Inhibitor in Anaplastic Thyroid Cancer.”. Oncotarget 10 (7): 686-87.
Publisher's Version
Last updated on 01/16/2026
PubMed